On September 10, the 2020 Big Health Industry High-Quality Development Conference and the 5th China Pharmaceutical R&D and Innovation Summit (PDI) kicked off grandly at the Chongqing Marriott Hotel. From September 10th to 11th, around the theme of "Formulation Innovation, Leading the Future", the conference was divided into the main forum on pharmaceutical formulation innovation and development, and sub-forums such as the discussion on key technologies for formulation development and the discussion on key technologies for sustained-release formulation development. Hundreds of experts and scholars from all over the country held heated discussions. In addition, Luo Ruichang, deputy general manager of our company, made a keynote report on "Discussion on Difficulties and Ideas in the Development of Peptide Products", pointing out that the market is huge and the advantages of peptide drugs are obvious, but the key to their consistency evaluation lies in the easily overlooked R&D technology.